Skip to main content
Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
0.741
-0.039 (-5.03%)
At close: Mar 9, 2026, 4:00 PM EDT
0.755
+0.014 (1.89%)
After-hours: Mar 9, 2026, 7:46 PM EDT

Scinai Immunotherapeutics Revenue

Scinai Immunotherapeutics had revenue of $386.50K in the quarter ending June 30, 2025, with 36.09% growth. This brings the company's revenue in the last twelve months to $1.15M, up 303.87% year-over-year. In the year 2024, Scinai Immunotherapeutics had annual revenue of $658.00K.

Revenue (ttm)
$1.15M
Revenue Growth
+303.87%
P/S Ratio
2.24
Revenue / Employee
$37,000
Employees
31
Market Cap
2.57M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024658.00K--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Jaguar Health 11.79M
60 Degrees Pharmaceuticals 1.36M
SciSparc 1.31M
PMGC Holdings 285.95K
Azitra 7.50K
Revenue Rankings

SCNI News

More News